Treatment with Selemax®, a selenium-enriched yeast, ameliorates experimental arthritis in rats and mice

British Journal of Nutrition

Volumn 108, Issue 10, 2012, Pages 1829-1838

  Vieira, Angélica T ^a   Silveira, Kátia D ^a   Arruda, Maria C C ^a   Fagundes, Caio T ^a   Gonçalves, Juliana L ^a   Silva, Tarcília A ^a   Neves, Maria J ^b   Menezes, Maria A B C ^b   Nicoli, Jacques R ^a   Teixeira, Mauro M ^a   Martins, Flaviano S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CENTRO DE DESENVOLVIMENTO DA TECNOLOGIA NUCLEAR   (Brazil)

Author keywords

Adjuvant induced arthritis; Antigen induced arthritis; Rheumatoid arthritis; Saccharomyces cerevisiae; Selenium

Indexed keywords

ANTIRHEUMATIC AGENT; CXCL1 CHEMOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; KERATINOCYTE DERIVED CHEMOKINE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SELEMAX; SELENIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; EX VIVO STUDY; FEMALE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PAW EDEMA; PERITONEUM MACROPHAGE; RAT; SACCHAROMYCES CEREVISIAE;

ANIMALS; ARTHRITIS; CYTOKINES; DIETARY SUPPLEMENTS; FEMALE; GENE EXPRESSION REGULATION; MACROPHAGES; MALE; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; NEUTROPHILS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SELENIUM; SERUM ALBUMIN, BOVINE; YEASTS;

ADIA; ANIMALIA; MUS; RATTUS; SACCHAROMYCES CEREVISIAE;

EID: 84870034006     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512000013     Document Type: Article

References (33)

1. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356-361.
2. Feldmann M, Brennan FM & Maini RN (1996) Role of cyto-kines in rheumatoid arthritis. Annu Rev Immunol 14, 397-440.
3. Arend WP (2001) Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum 45, 101-106.
4. Smolen JS & Steiner G (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2, 473-488.
5. Mirshafiey A & Mohsenzadegan M (2008) The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. J Allergy Asthma Immunol 4, 195-202.
6. Tayar JH & Suarez-Almazor ME (2010) New understanding and approaches to treatment in rheumatoid arthritis. Br Med Bull 94, 201-214.
7. Rayman MP (2000) The importance of selenium to human health. Lancet 356, 233-241.
8. Gärtner R (2009) Selenium and thyroid hormone axis in critical ill states: an overview of conflicting view points. J Trace Elem Med Biol 23, 71-74.
9. Parnham MJ, Winkelmann J & Leyck S (1983) Macrophage, lymphocyte and chronic inflammatory responses in selenium deficient rodents. Association with decreased glutathione peroxidase activity. Int J Immunopharmacol 5, 455-461.
10. Peretz A, Siderova V & Néve J (2001) Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo controlled trial. Scand J Rheumatol 30, 208-212.
11. COBEA. Colegio Brasileiro de Experimentação Animal (2006) Legislação e Ética. http://www.cobea.org.br/
12. Coelho FM, Pinho V, Amaral FA, et al. (2008) The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial micro-vasculature. Arthritis Rheum 8, 2329-2337.
13. Francischi JN, Yokoro CM, Poole S, et al. (2000) Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. Eur J Pharmacol 399, 243-249.
14. Vieira AT, Pinho V, Lepsch LB, et al. (2005) Mechanisms of the anti-inflammatory effects of the natural secosteroids phy-salins in a model of intestinal ischaemia and reperfusion injury. Br J Pharmacol 146, 244-251.
15. Menezes MABC & Jacimovic R (2006) Optimised k0-intrumental neutron activation method using the TRIGA MARK I IPR-R1 reactor at CDTN/CNEN, Belo Horizonte, Brazil. Nucl Instrum Methods Phys Res 564, 707-715.
16. Tatsuo MA, Carvalho WM, Silva CV, et al. (1994) Analgesic and anti-inflammatory effects of dipyrone in rat adjuvant arthritis model. Inflammation 18, 399-405.
17. Francischi JN, Pereira LS & Castro MS (1997) Cyclosporin inhibits hyperalgesia and edema in arthritic rats: role of the central nervous system. Braz J Med Biol Res 30, 101-111.
18. Arthur JR, McKenzie RC & Beckett GJ (2003) Selenium in the immune system. J Nutr 133, 1457-1459.
19. Firestein GS (2006) Inhibiting inflammation in rheumatoid arthritis. N Engl J Med 354, 80-82.
20. Grespan R, Fukada SY, Lemos HP, et al. (2008) CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis. Arthritis Rheum 58, 2030-2040.
21. Barsante MM, Cunha TM, Allegretti M, et al. (2008) Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. Br J Pharmacol 153, 992-1002.
22. Russo RC, Garcia CC & Teixeira MM (2010) Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists? Curr Opin Drug Discov Devel 13, 414-427.
23. Gabay C & McInnes IB (2009) The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases. Arthritis Res Ther 11, 230.
24. O'Dell JR, Lemley-Gillespie S, Palmer WR, et al. (1991) Serum selenium concentrations in rheumatoid arthritis. Ann Rheum Dis 50, 376-378.
25. Aaseth J, Haugen M & Førre O (1998) Rheumatoid arthritis and metal compounds-perspectives on the role of oxygen radical detoxification. Analyst 123, 3-6.
26. Prokopová A, Kéry V, Stancíková M, et al. (1993) Methyl-a-D-mannopyranoside, manno-oligosaccharides and yeast man-nans inhibit development of rat adjuvant arthritis. J Rheuma-tol 20, 673-677.
27. Kilpatrick DC (2003) Introduction to mannan-binding lectin. Biochem Soc Trans 31, 745-747.
28. Drábiková K, Perecko T, Nosál R, et al. (2009) Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis. Pharmacol Res 59, 399-403.
29. Seko Y & Imura N (1997) Active oxygen generation as a possible mechanism of selenium toxicity. Biomed Environ Sci 10, 333-339.
30. Vunta H, Davis F, Palempalli UD, et al. (2007) The anti-inflammatory effects of selenium are mediated through 15-deoxy-d 12, 14-prostaglandin J2 in macrophages. J Biol Chem 282, 17964-17973.
31. Roebuck KA (1999) Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med 3, 223-230.
32. Prabhu KS, Zamamiri-Davis F, Stewart JB, et al. (2002) Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264·7 macrophages: role of nuclear factor-kB in up-regulation. Biochem J 366, 203-209.
33. Zamamiri-Davis F, Lu Y, Thompson JT, et al. (2002) Nuclear factor-kB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 32, 890-897.